Sign inJoin waitlistJoin the waitlist

MP

Miguel-Angel Perales

Chief, Adult Bone Marrow Transplant Service · New York Presbyterian Hospital

Credentials: · · ·

History

Adult Bone Marrow Transplant Service Division · New York Presbyterian Hospital
Present
New York Presbyterian Hospital
Present

Weill Cornell Medical College
1997–1998
Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1994–1997
Internal Medicine
Tufts Medical Center
1991–1994
Vrije Universiteit Brussel Faculteit Geneeskunde & Farmacie
1987–1991

Research

Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
New England Journal of Medicine · 2022 · 1,350 citations
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation
Clinical Infectious Diseases · 2012 · 811 citations
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
Journal for ImmunoTherapy of Cancer · 2021 · 762 citations

SG
Sergio Giralt
180 papers
Gunjan Shah
108 papers · 1 as a fellow
AJ
Ann Jakubowski
96 papers
Craig Sauter
94 papers · 1 as a fellow
Michael Scordo
94 papers · 4 as a fellow
PD
Parastoo Dahi
91 papers
EP
Esperanza Papadopoulos
87 papers
DP
Doris Ponce
70 papers
Marcel van den Brink
70 papers
Juliet Barker
68 papers
RS
Roni Shouval
67 papers · 49 as a resident
RT
Roni Tamari
67 papers

Grants

BMT Core - MSK
National Heart, Lung, and Blood Institute · UG1
Contact PI · $2.2M · Sloan-Kettering Inst Can Research
2001–2031
Optimizing HCT Outcomes: A Multi-Omic Investigation
National Heart, Lung, and Blood Institute · R01
PI · $3.9M · Boston Children's Hospital
2025–2030
Immunoglobulin Replacement Therapy and Infectious Complications After CD19-Targeted CAR-T-Cell Therapy
National Cancer Institute · R01
PI · $3.3M · Fred Hutchinson Cancer Center
2023–2029
Immunobiology of Allogeneic Hematopoietic Cell Transplantation
National Cancer Institute · P01
Project lead · $2.9M · Sloan-Kettering Inst Can Research
1997–2025

Clinical trials

A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies
Principal investigator · Withdrawn · Phase 1
Memorial Sloan Kettering Cancer Center
2021–2022
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation
Principal investigator · Active not recruiting · Phase 2
Memorial Sloan Kettering Cancer Center
2012–2026
Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2007–2022
Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
Principal investigator · Completed · Early phase 1
Memorial Sloan Kettering Cancer Center
2003–2011